Market Closed -
OTC Markets
14:34:51 04/06/2024 BST
|
5-day change
|
1st Jan Change
|
3.75
USD
|
+1.90%
|
|
-6.25%
|
+69.68%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
12.64
|
11.78
|
5.276
|
11.19
|
5.276
|
5.424
|
Enterprise Value (EV)
1 |
11.26
|
9.963
|
4.871
|
9.935
|
4.193
|
4.879
|
P/E ratio
|
58.2
x
|
18.8
x
|
-5.66
x
|
16.9
x
|
-11.3
x
|
27.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.5
x
|
1.35
x
|
0.83
x
|
1.59
x
|
0.62
x
|
0.58
x
|
EV / Revenue
|
1.33
x
|
1.14
x
|
0.77
x
|
1.41
x
|
0.49
x
|
0.52
x
|
EV / EBITDA
|
16.8
x
|
11.2
x
|
-6.15
x
|
-4,918
x
|
49.1
x
|
70.3
x
|
EV / FCF
|
-272
x
|
428
x
|
-4.47
x
|
252
x
|
-33.7
x
|
-16.6
x
|
FCF Yield
|
-0.37%
|
0.23%
|
-22.4%
|
0.4%
|
-2.97%
|
-6.04%
|
Price to Book
|
2.05
x
|
1.73
x
|
0.89
x
|
1.7
x
|
0.86
x
|
0.85
x
|
Nbr of stocks (in thousands)
|
2,454
|
2,454
|
2,454
|
2,454
|
2,454
|
2,454
|
Reference price
2 |
5.150
|
4.800
|
2.150
|
4.560
|
2.150
|
2.210
|
Announcement Date
|
18/03/19
|
24/03/20
|
31/03/21
|
03/03/22
|
14/03/23
|
01/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
8.438
|
8.752
|
6.357
|
7.054
|
8.482
|
9.33
|
EBITDA
1 |
0.6722
|
0.8927
|
-0.7923
|
-0.00202
|
0.0853
|
0.0694
|
EBIT
1 |
0.2706
|
0.4812
|
-1.156
|
-0.2689
|
-0.5428
|
-0.1911
|
Operating Margin
|
3.21%
|
5.5%
|
-18.18%
|
-3.81%
|
-6.4%
|
-2.05%
|
Earnings before Tax (EBT)
1 |
0.2346
|
0.6874
|
-1.197
|
0.6197
|
-0.5727
|
-0.1626
|
Net income
1 |
0.2172
|
0.6258
|
-0.9219
|
0.676
|
-0.4558
|
0.2056
|
Net margin
|
2.57%
|
7.15%
|
-14.5%
|
9.58%
|
-5.37%
|
2.2%
|
EPS
2 |
0.0885
|
0.2550
|
-0.3800
|
0.2700
|
-0.1900
|
0.0800
|
Free Cash Flow
1 |
-0.0415
|
0.0233
|
-1.09
|
0.0394
|
-0.1244
|
-0.2945
|
FCF margin
|
-0.49%
|
0.27%
|
-17.15%
|
0.56%
|
-1.47%
|
-3.16%
|
FCF Conversion (EBITDA)
|
-
|
2.61%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
3.72%
|
-
|
5.84%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18/03/19
|
24/03/20
|
31/03/21
|
03/03/22
|
14/03/23
|
01/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1.38
|
1.82
|
0.41
|
1.26
|
1.08
|
0.54
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-0.04
|
0.02
|
-1.09
|
0.04
|
-0.12
|
-0.29
|
ROE (net income / shareholders' equity)
|
3.59%
|
9.66%
|
-14.5%
|
10.8%
|
-7.15%
|
3.29%
|
ROA (Net income/ Total Assets)
|
2.07%
|
3.48%
|
-8.22%
|
-1.92%
|
-3.88%
|
-1.39%
|
Assets
1 |
10.51
|
18
|
11.21
|
-35.16
|
11.73
|
-14.81
|
Book Value Per Share
2 |
2.510
|
2.770
|
2.400
|
2.690
|
2.510
|
2.590
|
Cash Flow per Share
2 |
1.140
|
1.300
|
0.8900
|
1.050
|
0.9600
|
0.7200
|
Capex
1 |
0.4
|
0.26
|
0.03
|
0.27
|
0.21
|
0.01
|
Capex / Sales
|
4.77%
|
2.94%
|
0.43%
|
3.77%
|
2.51%
|
0.07%
|
Announcement Date
|
18/03/19
|
24/03/20
|
31/03/21
|
03/03/22
|
14/03/23
|
01/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +69.68% | 9.03M | | +1.39% | 33.05B | | +20.13% | 8.48B | | +1.26% | 7.77B | | +21.25% | 5.54B | | +17.91% | 3.85B | | -11.78% | 3.81B | | +10.15% | 3.44B | | -8.30% | 2.77B | | -28.71% | 2.38B |
Testing & Measuring Equipment
|